These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 5476868)

  • 1. Sensitivity of Nocardia to trimethoprim and sulphonamides in vitro.
    Black WA; McNellis DA
    J Clin Pathol; 1970 Jul; 23(5):423-6. PubMed ID: 5476868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in-vitro sensitivity of Nocardia species to fusidic acid and sulphonamides.
    Black WA; McNellis DA
    J Med Microbiol; 1971 May; 4(2):293-5. PubMed ID: 5570106
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic nocardiosis treated with trimethoprim and sulphamethoxazole.
    Black WA; McNellis DA
    Lancet; 1970 Aug; 2(7670):473. PubMed ID: 4195156
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibacterial activity of diaveridine, trimethoprim, and selected sulfonamides in prostatic fluid.
    Carroll PT; Robb CA; Tippett LO; Langston JB
    Invest Urol; 1971 May; 8(6):686-94. PubMed ID: 4996092
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trimethoprim-sulfamethoxazole in the agar diffusion test. Comparison with tetracycline, chloramphenicol, gentamycin and sulfadiazine].
    Lentze I
    Med Klin; 1971 Nov; 66(45):1518-22. PubMed ID: 5000621
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of nocardial infection with trimethoprim-sulphamethoxazole.
    Pavillard ER
    Med J Aust; 1973 Jun; 1(2):Suppl:65-9. PubMed ID: 4580590
    [No Abstract]   [Full Text] [Related]  

  • 7. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R; Koch UJ
    Chemotherapy; 1973; 18(4):242-52. PubMed ID: 4571975
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trimethoprim. Folic acid antagonist--synergistic effect with sulphonamides].
    Lykkegaard Nielsen M; Laursen H
    Nord Med; 1970 Aug; 84(34):1070-3. PubMed ID: 4917032
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors influencing susceptibility of Nocardia species to trimethoprim-sulfamethoxazole.
    Bennett JE; Jennings AE
    Antimicrob Agents Chemother; 1978 Apr; 13(4):624-7. PubMed ID: 352260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nocardiosis: clinical and bacteriological aspects. Experience in 16 cases].
    Fernández M; Paredes L; Castillo M; Donoso A
    Rev Med Chil; 1987 Nov; 115(11):1053-60. PubMed ID: 3509826
    [No Abstract]   [Full Text] [Related]  

  • 11. Present significance of resistance to trimethoprim and sulphonamides in coliforms, Staphylococcus aureus, and Streptococcus faecalis.
    Lewis EL; Lacey RW
    J Clin Pathol; 1973 Mar; 26(3):175-80. PubMed ID: 4633678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics and mechanisms of action of trimethoprim and sulfonamides, alone or in combination, upon Escherichia coli.
    Seydel JK; Wempe E; Miller GH; Miller L
    Chemotherapy; 1972; 17(4):217-58. PubMed ID: 4557279
    [No Abstract]   [Full Text] [Related]  

  • 13. Complicated nocardiosis successfully treated with trimethoprim and sulphamethoxazole.
    Evans RA; Benson RE
    Med J Aust; 1971 Mar; 1(13):684-5. PubMed ID: 5553816
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy.
    Bushby SR
    Postgrad Med J; 1969 Nov; 45():Suppl:10-8. PubMed ID: 5361305
    [No Abstract]   [Full Text] [Related]  

  • 15. The in vivo and in vitro potentiation of sulfamethoxazole by trimethoprim against strains of Serratia marcescens.
    Grunberg E; Beskid G; DeLorenzo WF; Cleeland R
    Int J Clin Pharmacol; 1973 Aug; 8(1):47-50. PubMed ID: 4580383
    [No Abstract]   [Full Text] [Related]  

  • 16. [An unusual observation in agar diffusion tests with sulfonamides and sulfonamide combination sulfamethoxazol-trimethoprim].
    Hussels H; Hussels M
    Med Lab (Stuttg); 1971 Aug; 24(8):174-9. PubMed ID: 5569688
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance of Staphylococcus aureus to sulphamethoxazole and trimethoprim.
    Nakhla LS
    J Clin Pathol; 1972 Aug; 25(8):708-12. PubMed ID: 5076806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey.
    Brown-Elliott BA; Biehle J; Conville PS; Cohen S; Saubolle M; Sussland D; Wengenack N; Kriel K; Bridge L; McNulty S; Vasireddy R; Wallace RJ
    J Clin Microbiol; 2012 Mar; 50(3):670-2. PubMed ID: 22170936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of Pseudomonas aeruginosa to sulphonamides and trimethoprim and the activity of the combination trimethoprim: sulphamethoxazole.
    Grey D; Hamilton-Miller JM
    J Med Microbiol; 1977 Aug; 10(3):273-9. PubMed ID: 408490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of sulphonamides with diaminopyrimidines: how, when and why?
    Brumfitt W; Hamilton-Miller JM
    J Chemother; 1995 Apr; 7(2):136-9. PubMed ID: 7666120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.